Exponent Inc (EXPO) is not a strong buy for a beginner, long-term investor at the moment. While the company has shown steady financial growth and analysts see potential upside, the lack of significant positive catalysts, insider selling, and bearish technical indicators suggest waiting for a better entry point.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 66.038, with resistance at 68.351 and support at 63.725. This suggests limited immediate upside potential.

The company's financials show steady growth in revenue (+4.54% YoY), net income (+4.97% YoY), and EPS (+6.52% YoY). Analysts like JPMorgan see long-term upside potential with a price target of $95, citing strong fundamentals and a rebound in growth.
Insiders are selling heavily, with a 370.29% increase in selling activity over the last month. There are no recent news catalysts, and hedge funds are neutral on the stock. The bearish moving averages and lack of significant trading signals further dampen the immediate outlook.
In Q4 2025, Exponent reported revenue of $129.38M (+4.54% YoY), net income of $24.76M (+4.97% YoY), and EPS of $0.49 (+6.52% YoY). Gross margin remained stable at 100%. These figures indicate consistent but modest growth.
Analysts are mixed but leaning positive. JPMorgan maintains an Overweight rating with a price target of $95, citing strong fundamentals and growth potential. UBS raised its price target to $85 but maintains a Neutral rating, noting conservative guidance and potential upside.